Komori
Governance4559ZERIA PHARMACEUTICAL CO.,LTD.Pharmaceuticals

Independent Officer Notification Form

Kobayashi Satomi (児林 聡美) is scheduled to become a new outside director as of 26 June 2026 and has been reported as an independent officer. According to the filing, all 4 outside directors and 2 outside corporate auditors have been designated as independent officers.

Worth reading
33Immaterial
Scored from 1 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

Governance structure

Number of independent officers6Number

This is the number of people reported to the exchange as independent officers. Whether someone is an outside officer and whether they qualify as independent are separate determinations.

Changes this time

Kobayashi Satomi (児林 聡美) is scheduled to become a new outside director as of 26 June 2026. All outside officers who meet the qualifications for independent officer status have been designated as independent officers.

Governance structure
ItemDetails
Number of independent officers6
Changes this timeKobayashi Satomi (児林 聡美) is scheduled to become a new outside director as of 26 June 2026. All outside officers who meet the qualifications for independent officer status have been designated as independent officers.
Items this document does not state (6)
Corporate Governance StructureNumber of directorsCommitteePolicy on cross-shareholdingsTakeover defensesControlling shareholder

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Because an agenda item concerning the election of outside officers, including a new appointment, will be submitted to the annual general meeting of shareholders.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Independent Officer Notification Form | ZERIA PHARMACEUTICAL CO.,LTD. (4559) timely disclosure | Komori